Has Devin Mangold, MD received payments from drug or device companies?

Yes. Drug and device makers reported $27,533 in general payments to Devin Mangold, MD across 103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Devin Mangold, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Devin Mangold, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Devin Mangold, MD

Foot and Ankle Surgery · Fresno, CANPI 1326427444

Payments from drug & device makers

$27,533in general payments, 2019–2025

Across 103 payments — averaging $267.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lazurite Inc.$20K
Cornerstone Medical Associates, Inc.$3K
Arthrex$2K
Medical Device Business Services, Inc.$1K
Stryker$613
Johnson & Johnson$227
plus $427 from 4 others

What the payments were for

Travel & lodging$3,54147%
Food & beverage$2,79237%
Education$1,20016%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lazurite Inc.	2	$20,000
Cornerstone Medical Associates, Inc.	12	$3,144
Arthrex	24	$1,648
Medical Device Business Services, Inc.	11	$1,474
Stryker(2 entities)	8	$613
Johnson & Johnson	2	$227
Paragon 28, Inc.	40	$152
Exactech, Inc.	2	$133
Zimmer Biomet	1	$124
Bioventus LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,533 in reported general payments places this provider in the 90th percentile of 1,126 foot and ankle surgery providers in California.

See all foot and ankle surgery providers in California →

Medicare billing

Part B allowed, 2024

$243,978

Medicare patients

454

Services billed

2,923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	62	$191
Hydroxyzine Pamoate	38	$114

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Fresno

Francis GlaserFresno$128K
John ZimmermanBakersfield$4.6M
Eric GizaSacramento$3.7M
Thomas HarrisPasadena$3M
Felix SigalLos Angeles$2.2M
Thomas ChangSanta Rosa$2.1M
Michael CoughlinSan Francisco$1.6M
Vladimir ZeetserEncino$677K
Jason NowakRedding$526K
Candice BradyCamarillo$462K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →